These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32943095)

  • 21. In Vivo Detection of Changes Related to Cortical Columnar Organization and Neuroinflammation Across the AD Continuum.
    Torso M; Ridgway GR; Hardingham I; Schwarz AJ; Chance SA
    J Prev Alzheimers Dis; 2022; 9(4):769-779. PubMed ID: 36281682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrovascular function in presymptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case-control study.
    van Opstal AM; van Rooden S; van Harten T; Ghariq E; Labadie G; Fotiadis P; Gurol ME; Terwindt GM; Wermer MJH; van Buchem MA; Greenberg SM; van der Grond J
    Lancet Neurol; 2017 Feb; 16(2):115-122. PubMed ID: 27989553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network.
    Lee S; Viqar F; Zimmerman ME; Narkhede A; Tosto G; Benzinger TL; Marcus DS; Fagan AM; Goate A; Fox NC; Cairns NJ; Holtzman DM; Buckles V; Ghetti B; McDade E; Martins RN; Saykin AJ; Masters CL; Ringman JM; Ryan NS; Förster S; Laske C; Schofield PR; Sperling RA; Salloway S; Correia S; Jack C; Weiner M; Bateman RJ; Morris JC; Mayeux R; Brickman AM;
    Ann Neurol; 2016 Jun; 79(6):929-39. PubMed ID: 27016429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biphasic cortical macro- and microstructural changes in autosomal dominant Alzheimer's disease.
    Montal V; Vilaplana E; Pegueroles J; Bejanin A; Alcolea D; Carmona-Iragui M; Clarimón J; Levin J; Cruchaga C; Graff-Radford NR; Noble JM; Lee JH; Allegri R; Karch CM; Laske C; Schofield PR; Salloway S; Ances B; Benzinger T; McDale E; Bateman R; Blesa R; Sánchez-Valle R; Lleó A; Fortea J;
    Alzheimers Dement; 2021 Apr; 17(4):618-628. PubMed ID: 33196147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proximity to dementia onset and multi-modal neuroimaging changes: The prevent-dementia study.
    Mak E; Dounavi ME; Low A; Carter SF; McKiernan E; Williams GB; Jones PS; Carriere I; Muniz GT; Ritchie K; Ritchie C; Su L; O'Brien JT
    Neuroimage; 2021 Apr; 229():117749. PubMed ID: 33454416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo cortical diffusion imaging relates to Alzheimer's disease neuropathology.
    Torso M; Ridgway GR; Valotti M; Hardingham I; Chance SA; ;
    Alzheimers Res Ther; 2023 Oct; 15(1):165. PubMed ID: 37794477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion imaging changes in grey matter in Alzheimer's disease: a potential marker of early neurodegeneration.
    Weston PS; Simpson IJ; Ryan NS; Ourselin S; Fox NC
    Alzheimers Res Ther; 2015; 7(1):47. PubMed ID: 26136857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's disease.
    Araque Caballero MÁ; Suárez-Calvet M; Duering M; Franzmeier N; Benzinger T; Fagan AM; Bateman RJ; Jack CR; Levin J; Dichgans M; Jucker M; Karch C; Masters CL; Morris JC; Weiner M; Rossor M; Fox NC; Lee JH; Salloway S; Danek A; Goate A; Yakushev I; Hassenstab J; Schofield PR; Haass C; Ewers M
    Brain; 2018 Oct; 141(10):3065-3080. PubMed ID: 30239611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic and Environmental Influences on Structural and Diffusion-Based Alzheimer's Disease Neuroimaging Signatures Across Midlife and Early Old Age.
    Williams ME; Gillespie NA; Bell TR; Dale AM; Elman JA; Eyler LT; Fennema-Notestine C; Franz CE; Hagler DJ; Lyons MJ; McEvoy LK; Neale MC; Panizzon MS; Reynolds CA; Sanderson-Cimino M; Kremen WS
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Sep; 8(9):918-927. PubMed ID: 35738479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional Connectivity of Default Mode Network Subsystems in the Presymptomatic Stage of Autosomal Dominant Alzheimer's Disease.
    Zhao T; Quan M; Jia J
    J Alzheimers Dis; 2020; 73(4):1435-1444. PubMed ID: 31929167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mean diffusivity in cortical gray matter in Alzheimer's disease: The importance of partial volume correction.
    Henf J; Grothe MJ; Brueggen K; Teipel S; Dyrba M
    Neuroimage Clin; 2018; 17():579-586. PubMed ID: 29201644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease.
    Mosconi L; Sorbi S; de Leon MJ; Li Y; Nacmias B; Myoung PS; Tsui W; Ginestroni A; Bessi V; Fayyazz M; Caffarra P; Pupi A
    J Nucl Med; 2006 Nov; 47(11):1778-86. PubMed ID: 17079810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's disease.
    Vermunt L; Dicks E; Wang G; Dincer A; Flores S; Keefe SJ; Berman SB; Cash DM; Chhatwal JP; Cruchaga C; Fox NC; Ghetti B; Graff-Radford NR; Hassenstab J; Karch CM; Laske C; Levin J; Masters CL; McDade E; Mori H; Morris JC; Noble JM; Perrin RJ; Schofield PR; Xiong C; Scheltens P; Visser PJ; Bateman RJ; Benzinger TLS; Tijms BM; Gordon BA;
    Brain Commun; 2020; 2(2):fcaa102. PubMed ID: 32954344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolving brain structural changes in PSEN1 mutation carriers.
    Sala-Llonch R; Lladó A; Fortea J; Bosch B; Antonell A; Balasa M; Bargalló N; Bartrés-Faz D; Molinuevo JL; Sánchez-Valle R
    Neurobiol Aging; 2015 Mar; 36(3):1261-70. PubMed ID: 25638532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imaging.
    Parker TD; Slattery CF; Zhang J; Nicholas JM; Paterson RW; Foulkes AJM; Malone IB; Thomas DL; Modat M; Cash DM; Crutch SJ; Alexander DC; Ourselin S; Fox NC; Zhang H; Schott JM
    Hum Brain Mapp; 2018 Jul; 39(7):3005-3017. PubMed ID: 29575324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study.
    Ridha BH; Barnes J; Bartlett JW; Godbolt A; Pepple T; Rossor MN; Fox NC
    Lancet Neurol; 2006 Oct; 5(10):828-34. PubMed ID: 16987729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer's disease.
    Quan M; Zhao T; Tang Y; Luo P; Wang W; Qin Q; Li T; Wang Q; Fang J; Jia J
    Alzheimers Res Ther; 2020 Jan; 12(1):14. PubMed ID: 31937364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network.
    Ringman JM; Liang LJ; Zhou Y; Vangala S; Teng E; Kremen S; Wharton D; Goate A; Marcus DS; Farlow M; Ghetti B; McDade E; Masters CL; Mayeux RP; Rossor M; Salloway S; Schofield PR; Cummings JL; Buckles V; Bateman R; Morris JC;
    Brain; 2015 Apr; 138(Pt 4):1036-45. PubMed ID: 25688083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ERP generator anomalies in presymptomatic carriers of the Alzheimer's disease E280A PS-1 mutation.
    Bobes MA; García YF; Lopera F; Quiroz YT; Galán L; Vega M; Trujillo N; Valdes-Sosa M; Valdes-Sosa P
    Hum Brain Mapp; 2010 Feb; 31(2):247-65. PubMed ID: 19650138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.